AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.

scientific article published on 11 December 2006

AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RADONC.2006.11.007
P698PubMed publication ID17161478

P2093author name stringSait Okkan
Werner Dobrowsky
Hideo Tatsuzaki
Nagraj G Huigol
Noor-I-Alam Kizilbash
Ranapala S Jayatilake
V Tsutomu Kagiya
P433issue1
P921main subjectmulticenter clinical trialQ6934595
P304page(s)24-29
P577publication date2006-12-11
P1433published inRadiotherapy and OncologyQ14251029
P1476titleAK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
P478volume82

Reverse relations

cites work (P2860)
Q99416550Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives
Q38174090Current and emerging strategies to increase the efficacy of ionizing radiation in the treatment of cancer
Q53257786Differential cytotoxicity and sonosensitization by sanazole: effect of cell type and acoustic parameters.
Q45955620Enhancement of hyperthermia-induced apoptosis by sanazole in human lymphoma U937 cells.
Q42134569High Efficacy of Preoperative Low-Dose Radiotherapy with Sanazole (AK-2123) for Extraskeletal Ewing's Sarcoma: A Case Report
Q92696570Hypoxia-active nanoparticles used in tumor theranostic
Q39002822Hypoxia: A Double-Edged Sword in Cancer Therapy
Q35920685Modulation of the tumor vasculature and oxygenation to improve therapy
Q50177827Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths, and mistakes.
Q36243936Radiation enhancing effects of sanazole and gemcitabine in hypoxic breast and cervical cancer cells in vitro
Q35116798Six degrees of separation: the oxygen effect in the development of radiosensitizers.
Q39337383Synthesis, radiolabeling and biological evaluation of propylene amine oxime complexes containing nitrotriazoles as hypoxia markers.
Q26779537The impact of hypoxia and its modification of the outcome of radiotherapy

Search more.